Amber Implants clinical trials
Amber Implants is the lead sponsor of 3 current clinical trials in our Germany, USA and France registers. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Vertebral Compression Fracture.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Amber Implants
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures
NCT07301749 · ClinicalTrials.gov ↗ · Vertebral Compression Fracture
|
Not applicable | Recruiting | 2025-11 | Germany, France |
|
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
NCT07920484 · ClinicalTrials.gov ↗ · Vertebra Compression Fracture
|
Observational | Recruiting | 2026-10 | USA |
|
Vertebral Augmentation Using VCFix Spinal System in Stand-alone Configuration
NCT07259811 · ClinicalTrials.gov ↗ · Vertebral Compression Fracture
|
Not applicable | Active, closed | 2023-09 | Germany |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Amber Implants trials
2 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Germany | 2 | 1 |
| Clinical trials in USA | 1 | 1 |
| Clinical trials in France | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Vertebral Compression Fracture
| Sponsor | Trials |
|---|---|
| AgNovos Healthcare | 2 |
Sponsors with the most current trials registered for this condition.
Questions about Amber Implants trials
How many clinical trials does Amber Implants sponsor?
Amber Implants is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Germany, USA and France registers, as of the registry sync on 6 November 2026. Completed and withdrawn studies are not counted.
Are Amber Implants trials recruiting?
Yes. 2 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 6 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.